MPP And WHO Announce COVID Technology License Via C-TAP

Serological Antibody Technology Deal Struck With Spanish National Research Council

 
• By David Wallace
  
WHO
The WHO and MPP have announced a COVID-19 technology licensing deal • Source: Alamy

More from Legal & IP

More from Generics Bulletin